A Novel Approach to Treating Pruritus in Prurigo Nodularis

Time: 11:30 am
day: Day 1 AM - Track A


  • Rationalizing the dual mechanism of action approach as both an antagonist (mu opioid receptor) & agonist (kappa opioid receptor)
  • Providing fresh efficacy data from a phase 3 clinical trial
  • Addressing the challenges with entering the prurigo nodularis market